Genprex, Inc. (GNPX)
About Genprex, Inc.
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is initially being developed in combination with prominent, approved cancer drugs to treat Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC).
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2024
- $0
- Net income
- -$16.2M
- Total assets
- $10.2M
- Market cap
- $6.8M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating income
- -$15.5M
- Income tax
- $0
- Net income
- -$16.2M
- EPS (basic)
- $-17.40
Balance sheet
- Total assets
- $10.2M
- Current assets
- $8.4M
- Total liabilities
- $2.2M
- Current liabilities
- $2.2M
- Shareholders’ equity
- $8.0M
Cash flow
- Operating cash flow
- -$15.3M
- Investing cash flow
- -$6.2M
- Financing cash flow
- $21.5M
- Net cash flow
- $0
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $6.8M
- Shares outstanding
- 876.6K
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Mar 29, 2018
Genprex, Inc. (GNPX) Stock Price
- Reported a net loss of $16.2M in FY2024.
- Trading 99% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Genprex, Inc..
Write a review
News about Genprex, Inc.
News & sentiment via Polygon.io
Genprex, Inc.: frequently asked questions
Is Genprex, Inc. an American company?
Genprex, Inc. is a US-based company headquartered in Austin, Texas, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Genprex, Inc. headquartered?
Genprex, Inc. is headquartered in Austin, Texas, United States.
Is Genprex, Inc. publicly traded?
Yes — Genprex, Inc. is a publicly traded company. Its stock trades under the ticker symbol GNPX on the NASDAQ.
What does Genprex, Inc. do?
Genprex, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
